Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€10.10
22.08.22
€10.00
22.08.23
-13.85%
23.08.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Energy Recovery

Start price
Target price
Perf. (%)
€17.20
03.08.21
€20.00
03.08.22
24.07%
29.07.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Now Inc.

Start price
Target price
Perf. (%)
€6.30
27.10.21
€7.50
27.10.22
60.32%
10.07.22

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
27.06.22
€1.00
27.06.23
26.17%
09.07.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Revlon Inc.

Start price
Target price
Perf. (%)
€1.06
13.06.22
€1.00
13.06.23
159.41%
14.06.22

Could be very worthwhile Investment >20% year
Capable Management
Good culture
Few uniques
buy
Capital Bancorp Inc

Start price
Target price
Perf. (%)
€20.20
04.06.21
€20.00
04.06.22
5.94%
05.06.22

Could be worthwhile Investment >10% per year
buy
Ingles Markets Inc

Start price
Target price
Perf. (%)
€50.00
23.05.21
€60.00
23.05.22
61.00%
24.05.22

Could be worthwhile Investment >10% per year
buy
Boise Cascade Co

Start price
Target price
Perf. (%)
€52.00
18.05.21
€76.00
18.05.22
45.19%
19.05.22

Could be worthwhile Investment >10% per year
Fair valuation
Good rating
negative Cash Flow expected
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
buy
Pra Group Inc

Start price
Target price
Perf. (%)
€31.20
01.05.21
€33.00
01.05.22
27.56%
02.05.22

Could be worthwhile Investment >10% per year
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€28.67
07.03.22
€21.00
07.03.23
-33.73%
07.03.22

Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
buy
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€7.20
27.02.21
€12.00
27.02.22
109.58%
28.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
ROE higher than 10% per year
Growths much faster than the competition
buy
Gtt Communications Inc

Start price
Target price
Perf. (%)
€1.56
27.02.21
€2.00
27.02.22
28.21%
28.02.22

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Capable Management
Small Risks for its business
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€13.13
21.02.22
€25.00
21.02.23
-7.07%
23.02.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Arcimoto Inc

Start price
Target price
Perf. (%)
€4.70
20.02.22
€6.00
20.02.23
0.43%
22.02.22

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
buy
Greenhill & Co.inc.

Start price
Target price
Perf. (%)
€13.00
06.02.21
€15.00
06.02.22
20.00%
05.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
buy
Axonics Modulation Technologies Inc

Start price
Target price
Perf. (%)
€37.20
28.11.20
€42.00
28.11.21
31.72%
29.11.21

Could be worthwhile Investment >10% per year